ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Biopharma Potency Assays Market Research Report 2025
Published Date: April 2025
|
Report Code: QYRE-Auto-36O13443
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Biopharma Potency Assays Market Research Report 2023
BUY CHAPTERS

Global Biopharma Potency Assays Market Research Report 2025

Code: QYRE-Auto-36O13443
Report
April 2025
Pages:89
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
ARL Bio Pharma
BioPharm International
Charles River Laboratories
DiscoveRx
Eurofins Scientific
Intertek
Kymos S.L.
Pacific Biolabs
Pharmaron
Promega
Sartorius
SGS Ltd
ViruSure
Zelle Biotechnology

Biopharma Potency Assays Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Biopharma Potency Assays Market

Biopharma Potency Assays Market

The global market for Biopharma Potency Assays was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Biopharma Potency Assays, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biopharma Potency Assays.
The Biopharma Potency Assays market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Biopharma Potency Assays market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biopharma Potency Assays companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Biopharma Potency Assays Market Report

Report Metric Details
Report Name Biopharma Potency Assays Market
CAGR 5%
Segment by Type
  • Intracellular Potency Assay
  • Extracellular Potency Assay
Segment by Application
  • Pharmaceutical
  • Cytology
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company ARL Bio Pharma, BioPharm International, Charles River Laboratories, DiscoverX, Eurofins Scientific, Intertek, Kymos, Pacific BioLabs, Pharmaron, Promega, Sartorius, SGS, ViruSure, Zelle Biotechnology
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Biopharma Potency Assays company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Biopharma Potency Assays Market report?

Ans: The main players in the Biopharma Potency Assays Market are ARL Bio Pharma, BioPharm International, Charles River Laboratories, DiscoverX, Eurofins Scientific, Intertek, Kymos, Pacific BioLabs, Pharmaron, Promega, Sartorius, SGS, ViruSure, Zelle Biotechnology

What are the Application segmentation covered in the Biopharma Potency Assays Market report?

Ans: The Applications covered in the Biopharma Potency Assays Market report are Pharmaceutical, Cytology, Other

What are the Type segmentation covered in the Biopharma Potency Assays Market report?

Ans: The Types covered in the Biopharma Potency Assays Market report are Intracellular Potency Assay, Extracellular Potency Assay

Recommended Reports

Biopharma Testing Services

Diagnostics And Biomarkers

Pharmaceutical Manufacturing

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biopharma Potency Assays Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Intracellular Potency Assay
1.2.3 Extracellular Potency Assay
1.3 Market by Application
1.3.1 Global Biopharma Potency Assays Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical
1.3.3 Cytology
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biopharma Potency Assays Market Perspective (2020-2031)
2.2 Global Biopharma Potency Assays Growth Trends by Region
2.2.1 Global Biopharma Potency Assays Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Biopharma Potency Assays Historic Market Size by Region (2020-2025)
2.2.3 Biopharma Potency Assays Forecasted Market Size by Region (2026-2031)
2.3 Biopharma Potency Assays Market Dynamics
2.3.1 Biopharma Potency Assays Industry Trends
2.3.2 Biopharma Potency Assays Market Drivers
2.3.3 Biopharma Potency Assays Market Challenges
2.3.4 Biopharma Potency Assays Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biopharma Potency Assays Players by Revenue
3.1.1 Global Top Biopharma Potency Assays Players by Revenue (2020-2025)
3.1.2 Global Biopharma Potency Assays Revenue Market Share by Players (2020-2025)
3.2 Global Biopharma Potency Assays Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Biopharma Potency Assays Revenue
3.4 Global Biopharma Potency Assays Market Concentration Ratio
3.4.1 Global Biopharma Potency Assays Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biopharma Potency Assays Revenue in 2024
3.5 Global Key Players of Biopharma Potency Assays Head office and Area Served
3.6 Global Key Players of Biopharma Potency Assays, Product and Application
3.7 Global Key Players of Biopharma Potency Assays, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Biopharma Potency Assays Breakdown Data by Type
4.1 Global Biopharma Potency Assays Historic Market Size by Type (2020-2025)
4.2 Global Biopharma Potency Assays Forecasted Market Size by Type (2026-2031)
5 Biopharma Potency Assays Breakdown Data by Application
5.1 Global Biopharma Potency Assays Historic Market Size by Application (2020-2025)
5.2 Global Biopharma Potency Assays Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Biopharma Potency Assays Market Size (2020-2031)
6.2 North America Biopharma Potency Assays Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Biopharma Potency Assays Market Size by Country (2020-2025)
6.4 North America Biopharma Potency Assays Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biopharma Potency Assays Market Size (2020-2031)
7.2 Europe Biopharma Potency Assays Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Biopharma Potency Assays Market Size by Country (2020-2025)
7.4 Europe Biopharma Potency Assays Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biopharma Potency Assays Market Size (2020-2031)
8.2 Asia-Pacific Biopharma Potency Assays Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Biopharma Potency Assays Market Size by Region (2020-2025)
8.4 Asia-Pacific Biopharma Potency Assays Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Biopharma Potency Assays Market Size (2020-2031)
9.2 Latin America Biopharma Potency Assays Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Biopharma Potency Assays Market Size by Country (2020-2025)
9.4 Latin America Biopharma Potency Assays Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biopharma Potency Assays Market Size (2020-2031)
10.2 Middle East & Africa Biopharma Potency Assays Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Biopharma Potency Assays Market Size by Country (2020-2025)
10.4 Middle East & Africa Biopharma Potency Assays Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 ARL Bio Pharma
11.1.1 ARL Bio Pharma Company Details
11.1.2 ARL Bio Pharma Business Overview
11.1.3 ARL Bio Pharma Biopharma Potency Assays Introduction
11.1.4 ARL Bio Pharma Revenue in Biopharma Potency Assays Business (2020-2025)
11.1.5 ARL Bio Pharma Recent Development
11.2 BioPharm International
11.2.1 BioPharm International Company Details
11.2.2 BioPharm International Business Overview
11.2.3 BioPharm International Biopharma Potency Assays Introduction
11.2.4 BioPharm International Revenue in Biopharma Potency Assays Business (2020-2025)
11.2.5 BioPharm International Recent Development
11.3 Charles River Laboratories
11.3.1 Charles River Laboratories Company Details
11.3.2 Charles River Laboratories Business Overview
11.3.3 Charles River Laboratories Biopharma Potency Assays Introduction
11.3.4 Charles River Laboratories Revenue in Biopharma Potency Assays Business (2020-2025)
11.3.5 Charles River Laboratories Recent Development
11.4 DiscoverX
11.4.1 DiscoverX Company Details
11.4.2 DiscoverX Business Overview
11.4.3 DiscoverX Biopharma Potency Assays Introduction
11.4.4 DiscoverX Revenue in Biopharma Potency Assays Business (2020-2025)
11.4.5 DiscoverX Recent Development
11.5 Eurofins Scientific
11.5.1 Eurofins Scientific Company Details
11.5.2 Eurofins Scientific Business Overview
11.5.3 Eurofins Scientific Biopharma Potency Assays Introduction
11.5.4 Eurofins Scientific Revenue in Biopharma Potency Assays Business (2020-2025)
11.5.5 Eurofins Scientific Recent Development
11.6 Intertek
11.6.1 Intertek Company Details
11.6.2 Intertek Business Overview
11.6.3 Intertek Biopharma Potency Assays Introduction
11.6.4 Intertek Revenue in Biopharma Potency Assays Business (2020-2025)
11.6.5 Intertek Recent Development
11.7 Kymos
11.7.1 Kymos Company Details
11.7.2 Kymos Business Overview
11.7.3 Kymos Biopharma Potency Assays Introduction
11.7.4 Kymos Revenue in Biopharma Potency Assays Business (2020-2025)
11.7.5 Kymos Recent Development
11.8 Pacific BioLabs
11.8.1 Pacific BioLabs Company Details
11.8.2 Pacific BioLabs Business Overview
11.8.3 Pacific BioLabs Biopharma Potency Assays Introduction
11.8.4 Pacific BioLabs Revenue in Biopharma Potency Assays Business (2020-2025)
11.8.5 Pacific BioLabs Recent Development
11.9 Pharmaron
11.9.1 Pharmaron Company Details
11.9.2 Pharmaron Business Overview
11.9.3 Pharmaron Biopharma Potency Assays Introduction
11.9.4 Pharmaron Revenue in Biopharma Potency Assays Business (2020-2025)
11.9.5 Pharmaron Recent Development
11.10 Promega
11.10.1 Promega Company Details
11.10.2 Promega Business Overview
11.10.3 Promega Biopharma Potency Assays Introduction
11.10.4 Promega Revenue in Biopharma Potency Assays Business (2020-2025)
11.10.5 Promega Recent Development
11.11 Sartorius
11.11.1 Sartorius Company Details
11.11.2 Sartorius Business Overview
11.11.3 Sartorius Biopharma Potency Assays Introduction
11.11.4 Sartorius Revenue in Biopharma Potency Assays Business (2020-2025)
11.11.5 Sartorius Recent Development
11.12 SGS
11.12.1 SGS Company Details
11.12.2 SGS Business Overview
11.12.3 SGS Biopharma Potency Assays Introduction
11.12.4 SGS Revenue in Biopharma Potency Assays Business (2020-2025)
11.12.5 SGS Recent Development
11.13 ViruSure
11.13.1 ViruSure Company Details
11.13.2 ViruSure Business Overview
11.13.3 ViruSure Biopharma Potency Assays Introduction
11.13.4 ViruSure Revenue in Biopharma Potency Assays Business (2020-2025)
11.13.5 ViruSure Recent Development
11.14 Zelle Biotechnology
11.14.1 Zelle Biotechnology Company Details
11.14.2 Zelle Biotechnology Business Overview
11.14.3 Zelle Biotechnology Biopharma Potency Assays Introduction
11.14.4 Zelle Biotechnology Revenue in Biopharma Potency Assays Business (2020-2025)
11.14.5 Zelle Biotechnology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
ARL Bio Pharma
BioPharm International
Charles River Laboratories
DiscoveRx
Eurofins Scientific
Intertek
Kymos S.L.
Pacific Biolabs
Pharmaron
Promega
Sartorius
SGS Ltd
ViruSure
Zelle Biotechnology
List of Tables
 Table 1. Global Biopharma Potency Assays Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Intracellular Potency Assay
 Table 3. Key Players of Extracellular Potency Assay
 Table 4. Global Biopharma Potency Assays Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Biopharma Potency Assays Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Biopharma Potency Assays Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Biopharma Potency Assays Market Share by Region (2020-2025)
 Table 8. Global Biopharma Potency Assays Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Biopharma Potency Assays Market Share by Region (2026-2031)
 Table 10. Biopharma Potency Assays Market Trends
 Table 11. Biopharma Potency Assays Market Drivers
 Table 12. Biopharma Potency Assays Market Challenges
 Table 13. Biopharma Potency Assays Market Restraints
 Table 14. Global Biopharma Potency Assays Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Biopharma Potency Assays Market Share by Players (2020-2025)
 Table 16. Global Top Biopharma Potency Assays Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharma Potency Assays as of 2024)
 Table 17. Ranking of Global Top Biopharma Potency Assays Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Biopharma Potency Assays Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Biopharma Potency Assays, Headquarters and Area Served
 Table 20. Global Key Players of Biopharma Potency Assays, Product and Application
 Table 21. Global Key Players of Biopharma Potency Assays, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Biopharma Potency Assays Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Biopharma Potency Assays Revenue Market Share by Type (2020-2025)
 Table 25. Global Biopharma Potency Assays Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Biopharma Potency Assays Revenue Market Share by Type (2026-2031)
 Table 27. Global Biopharma Potency Assays Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Biopharma Potency Assays Revenue Market Share by Application (2020-2025)
 Table 29. Global Biopharma Potency Assays Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Biopharma Potency Assays Revenue Market Share by Application (2026-2031)
 Table 31. North America Biopharma Potency Assays Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Biopharma Potency Assays Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Biopharma Potency Assays Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Biopharma Potency Assays Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Biopharma Potency Assays Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Biopharma Potency Assays Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Biopharma Potency Assays Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Biopharma Potency Assays Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Biopharma Potency Assays Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Biopharma Potency Assays Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Biopharma Potency Assays Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Biopharma Potency Assays Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Biopharma Potency Assays Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Biopharma Potency Assays Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Biopharma Potency Assays Market Size by Country (2026-2031) & (US$ Million)
 Table 46. ARL Bio Pharma Company Details
 Table 47. ARL Bio Pharma Business Overview
 Table 48. ARL Bio Pharma Biopharma Potency Assays Product
 Table 49. ARL Bio Pharma Revenue in Biopharma Potency Assays Business (2020-2025) & (US$ Million)
 Table 50. ARL Bio Pharma Recent Development
 Table 51. BioPharm International Company Details
 Table 52. BioPharm International Business Overview
 Table 53. BioPharm International Biopharma Potency Assays Product
 Table 54. BioPharm International Revenue in Biopharma Potency Assays Business (2020-2025) & (US$ Million)
 Table 55. BioPharm International Recent Development
 Table 56. Charles River Laboratories Company Details
 Table 57. Charles River Laboratories Business Overview
 Table 58. Charles River Laboratories Biopharma Potency Assays Product
 Table 59. Charles River Laboratories Revenue in Biopharma Potency Assays Business (2020-2025) & (US$ Million)
 Table 60. Charles River Laboratories Recent Development
 Table 61. DiscoverX Company Details
 Table 62. DiscoverX Business Overview
 Table 63. DiscoverX Biopharma Potency Assays Product
 Table 64. DiscoverX Revenue in Biopharma Potency Assays Business (2020-2025) & (US$ Million)
 Table 65. DiscoverX Recent Development
 Table 66. Eurofins Scientific Company Details
 Table 67. Eurofins Scientific Business Overview
 Table 68. Eurofins Scientific Biopharma Potency Assays Product
 Table 69. Eurofins Scientific Revenue in Biopharma Potency Assays Business (2020-2025) & (US$ Million)
 Table 70. Eurofins Scientific Recent Development
 Table 71. Intertek Company Details
 Table 72. Intertek Business Overview
 Table 73. Intertek Biopharma Potency Assays Product
 Table 74. Intertek Revenue in Biopharma Potency Assays Business (2020-2025) & (US$ Million)
 Table 75. Intertek Recent Development
 Table 76. Kymos Company Details
 Table 77. Kymos Business Overview
 Table 78. Kymos Biopharma Potency Assays Product
 Table 79. Kymos Revenue in Biopharma Potency Assays Business (2020-2025) & (US$ Million)
 Table 80. Kymos Recent Development
 Table 81. Pacific BioLabs Company Details
 Table 82. Pacific BioLabs Business Overview
 Table 83. Pacific BioLabs Biopharma Potency Assays Product
 Table 84. Pacific BioLabs Revenue in Biopharma Potency Assays Business (2020-2025) & (US$ Million)
 Table 85. Pacific BioLabs Recent Development
 Table 86. Pharmaron Company Details
 Table 87. Pharmaron Business Overview
 Table 88. Pharmaron Biopharma Potency Assays Product
 Table 89. Pharmaron Revenue in Biopharma Potency Assays Business (2020-2025) & (US$ Million)
 Table 90. Pharmaron Recent Development
 Table 91. Promega Company Details
 Table 92. Promega Business Overview
 Table 93. Promega Biopharma Potency Assays Product
 Table 94. Promega Revenue in Biopharma Potency Assays Business (2020-2025) & (US$ Million)
 Table 95. Promega Recent Development
 Table 96. Sartorius Company Details
 Table 97. Sartorius Business Overview
 Table 98. Sartorius Biopharma Potency Assays Product
 Table 99. Sartorius Revenue in Biopharma Potency Assays Business (2020-2025) & (US$ Million)
 Table 100. Sartorius Recent Development
 Table 101. SGS Company Details
 Table 102. SGS Business Overview
 Table 103. SGS Biopharma Potency Assays Product
 Table 104. SGS Revenue in Biopharma Potency Assays Business (2020-2025) & (US$ Million)
 Table 105. SGS Recent Development
 Table 106. ViruSure Company Details
 Table 107. ViruSure Business Overview
 Table 108. ViruSure Biopharma Potency Assays Product
 Table 109. ViruSure Revenue in Biopharma Potency Assays Business (2020-2025) & (US$ Million)
 Table 110. ViruSure Recent Development
 Table 111. Zelle Biotechnology Company Details
 Table 112. Zelle Biotechnology Business Overview
 Table 113. Zelle Biotechnology Biopharma Potency Assays Product
 Table 114. Zelle Biotechnology Revenue in Biopharma Potency Assays Business (2020-2025) & (US$ Million)
 Table 115. Zelle Biotechnology Recent Development
 Table 116. Research Programs/Design for This Report
 Table 117. Key Data Information from Secondary Sources
 Table 118. Key Data Information from Primary Sources
 Table 119. Authors List of This Report


List of Figures
 Figure 1. Biopharma Potency Assays Picture
 Figure 2. Global Biopharma Potency Assays Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Biopharma Potency Assays Market Share by Type: 2024 VS 2031
 Figure 4. Intracellular Potency Assay Features
 Figure 5. Extracellular Potency Assay Features
 Figure 6. Global Biopharma Potency Assays Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Biopharma Potency Assays Market Share by Application: 2024 VS 2031
 Figure 8. Pharmaceutical Case Studies
 Figure 9. Cytology Case Studies
 Figure 10. Other Case Studies
 Figure 11. Biopharma Potency Assays Report Years Considered
 Figure 12. Global Biopharma Potency Assays Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 13. Global Biopharma Potency Assays Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Biopharma Potency Assays Market Share by Region: 2024 VS 2031
 Figure 15. Global Biopharma Potency Assays Market Share by Players in 2024
 Figure 16. Global Top Biopharma Potency Assays Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharma Potency Assays as of 2024)
 Figure 17. The Top 10 and 5 Players Market Share by Biopharma Potency Assays Revenue in 2024
 Figure 18. North America Biopharma Potency Assays Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 19. North America Biopharma Potency Assays Market Share by Country (2020-2031)
 Figure 20. United States Biopharma Potency Assays Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Canada Biopharma Potency Assays Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe Biopharma Potency Assays Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Biopharma Potency Assays Market Share by Country (2020-2031)
 Figure 24. Germany Biopharma Potency Assays Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. France Biopharma Potency Assays Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. U.K. Biopharma Potency Assays Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Italy Biopharma Potency Assays Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Russia Biopharma Potency Assays Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Nordic Countries Biopharma Potency Assays Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific Biopharma Potency Assays Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Biopharma Potency Assays Market Share by Region (2020-2031)
 Figure 32. China Biopharma Potency Assays Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Japan Biopharma Potency Assays Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. South Korea Biopharma Potency Assays Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Southeast Asia Biopharma Potency Assays Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. India Biopharma Potency Assays Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Australia Biopharma Potency Assays Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America Biopharma Potency Assays Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Biopharma Potency Assays Market Share by Country (2020-2031)
 Figure 40. Mexico Biopharma Potency Assays Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Brazil Biopharma Potency Assays Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa Biopharma Potency Assays Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Biopharma Potency Assays Market Share by Country (2020-2031)
 Figure 44. Turkey Biopharma Potency Assays Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Saudi Arabia Biopharma Potency Assays Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. UAE Biopharma Potency Assays Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. ARL Bio Pharma Revenue Growth Rate in Biopharma Potency Assays Business (2020-2025)
 Figure 48. BioPharm International Revenue Growth Rate in Biopharma Potency Assays Business (2020-2025)
 Figure 49. Charles River Laboratories Revenue Growth Rate in Biopharma Potency Assays Business (2020-2025)
 Figure 50. DiscoverX Revenue Growth Rate in Biopharma Potency Assays Business (2020-2025)
 Figure 51. Eurofins Scientific Revenue Growth Rate in Biopharma Potency Assays Business (2020-2025)
 Figure 52. Intertek Revenue Growth Rate in Biopharma Potency Assays Business (2020-2025)
 Figure 53. Kymos Revenue Growth Rate in Biopharma Potency Assays Business (2020-2025)
 Figure 54. Pacific BioLabs Revenue Growth Rate in Biopharma Potency Assays Business (2020-2025)
 Figure 55. Pharmaron Revenue Growth Rate in Biopharma Potency Assays Business (2020-2025)
 Figure 56. Promega Revenue Growth Rate in Biopharma Potency Assays Business (2020-2025)
 Figure 57. Sartorius Revenue Growth Rate in Biopharma Potency Assays Business (2020-2025)
 Figure 58. SGS Revenue Growth Rate in Biopharma Potency Assays Business (2020-2025)
 Figure 59. ViruSure Revenue Growth Rate in Biopharma Potency Assays Business (2020-2025)
 Figure 60. Zelle Biotechnology Revenue Growth Rate in Biopharma Potency Assays Business (2020-2025)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

Pharmacokinetic Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
High density Multiplexed Diagnostic Assays Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Vitro Diagnostics Reagents Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Automation in Biopharma Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global BioPharma Service Market Research Report 2024
Biopharma Cosmetics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Point of Care Diagnostic and Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Biopharmaceuticals Manufacturing Consumables Testing Market Research Report 2024
Global Pharmaceutical Products Testing Market Research Report 2025
Biopharma Contract Manufacturing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Biopharmaceutical Biopharma Autoclaves Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Marine Biopharmaceutical Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pharmaceutical Stability Testing Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Laboratory Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Drug Stability Testing Market Research Report 2025
Molecular Diagnostics Tests Reagents Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pharmaceutical Retail Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Drug Stability Testing Services Market Research Report 2025
Lab Automation in Drug Discovery Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Bulk Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions